It is worth emphasising that peripheral oedema (swelling of the ankles, feet, or hands) is not listed among the common or uncommon side effects in the official prescribing information
Other medication-related exclusions included use of antiobesity medications, nutritional supplements or over-the-counter products for weight loss within 3 months prior to screening
It also frames medication as an addition to continued lifestyle support rather than a replacement for it
Retatrutide , an investigational medication developed by Eli Lilly and Company, is showing unprecedented results in clinical trials
Obesity & Type 2 Diabetes Studies Evaluation of chronic semaglutide exposure on body-weight reduction, hepatic steatosis, and HbA1c modulation in diet-induced obesity models
Corrections 23 Sep 2015: The PLOS ONE Staff (2015) Correction: Correction: Acetyl-L-carnitine in the Treatment of Peripheral Neuropathic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials